Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Anti-hemagglutinin monomeric nanobody provides prophylactic immunity against H1 subtype influenza A viruses

PLoS ONE(2024)10.1371/journal.pone.0301664Source: DataRank Database

Anti-hemagglutinin monomeric nanobody provides prophylactic immunity against H1 subtype influenza A viruses is a research paper published in PLoS ONE (2024). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

gen pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 3.11)OA: goldTopics (31)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Carla Sosa-Holt,Lorena Itatí Ibañez ORCID,Josefina Baztarrica,Lorena Garaicoechea,C. Gay ORCID

Live enrichment

PubMed:38985719 PMC:PMC11236207 OpenAlex:https://openalex.org/W4400489812

CONICET

Grant: Doctorade fellowship. 2019-2022. Finalized

ANPYCT

Grant: PICT 2014- 1437. Finalized.

Fulbright Association

Grant: Posdoctoral researcher. Cohort 2021. Completed

FWCI

3.11

Citation Percentile

0.9%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1371/journal.pone.0301664

publisherhttps://doi.org/10.1371/journal.pone.0301664

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38985719

repositoryhttp://hdl.handle.net/11336/265947

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/11236207

Fields of Study

Influenza Virus Research StudiesRespiratory viral infections researchSARS-CoV-2 and COVID-19 Research

MeSH Terms

AnimalsAntibodies, ViralEpitopesCamelids, New WorldDogsFemaleHumansInfluenza, HumanMice, Inbred BALB COrthomyxoviridae InfectionsHemagglutinin Glycoproteins, Influenza VirusMiceInfluenza A Virus, H1N1 SubtypeAntibodies, NeutralizingSingle-Domain Antibodies

Keywords

Hemagglutinin (influenza)VirologyImmunityInfluenza A virusH5N1 genetic structureBiologyMicrobiologyVirusMedicineImmune systemImmunologyCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)

Sustainable Development Goals

SDG 0: Good health and well-being

Anti-hemagglutinin monomeric nanobody provides prophylactic immunity against H1 subtype influenza A viruses

FAIR Checklist

Authors (14)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)